Publicaciones en las que colabora con Eugenio Chamizo Carmona (10)

2024

  1. Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice

    Reumatologia Clinica, Vol. 20, Núm. 1, pp. 24-31

2022

  1. Recommendations for prevention of infection in systemic autoimmune rheumatic diseases

    Reumatologia Clinica, Vol. 18, Núm. 6, pp. 317-330

2021

  1. Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions

    Aging Clinical and Experimental Research, Vol. 33, Núm. 11, pp. 2929-2939

2019

  1. A composite indicator to assess the quality of care in the management of patients with rheumatoid arthritis in outpatient rheumatology clinics

    Reumatologia Clinica, Vol. 15, Núm. 3, pp. 156-164

2018

  1. Biologic Disease-modifying antirheumatic drug attributes in the first lines of treatment of rheumatoid arthritis. 2015 ACORDAR project

    Reumatologia Clinica, Vol. 14, Núm. 2, pp. 90-96

2017

  1. Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort

    Arthritis Care and Research, Vol. 69, Núm. 6, pp. 938-942

  2. Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis

    Arthritis Care and Research, Vol. 69, Núm. 1, pp. 150-155

  3. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

2016

  1. Differences between familial and sporadic early spondyloarthritis: Results from the ESPERANZA cohort

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 4, pp. 575-580

2006

  1. Implementación y características de la población del estudio ArthRoCad, una aproximación al consumo de recursos y repercusión socioeconómica de la artrosis de rodilla y cadera en atención primaria

    Reumatologia Clinica, Vol. 2, Núm. 5, pp. 224-234